WEISMAN HOWARD J. (Chief Executive Officer) reported 1 transaction at KUVATRIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/28/2023ACC: 0001062993-23-015429
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-9.95K
Net shares
Net seller
$7.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.95K
Price / share
$0.72
Trade value
$7.14K
% of position
1.4%
7/26/2023
711.68K→701.73K
Total
Net shares
−9.95K
Net value
-$7.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/26/2023 | F · Tax Withholding | −9.95K | $0.72 | $7.14K | 1.4% | 711.68K | 701.73K |
| Total | −9.95K | -$7.14K | ||||||
Derivative Transactions0
No derivative transactions reported